Combination chemotherapy with a five-drug regimen for invasive thymoma

Acta Oncologica

Volumn 35, Issue 1, 1996, Pages 71-73

  Bjerrum, Ole W ^a   Kiss, Katalin ^a   Daugaard, Gedske ^a  

^a Rigshospitalet   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; LOMUSTINE; PREDNISOLONE; VINCRISTINE;

ADULT; AGED; ARTICLE; BLOOD TOXICITY; CLINICAL ARTICLE; COMBINATION CHEMOTHERAPY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; NEPHROTOXICITY; NEUROTOXICITY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; THYMOMA;

EID: 0029928018     PISSN: 0284186X     EISSN: None     Source Type: Journal    
DOI: 10.3109/02841869609098482     Document Type: Article

References (19)

1. Maggi G, Giaccone G, Donadio M, et al. Thymomas. A review of 169 cases, with particular reference to results of surgical treatment. Cancer 1986; 58: 765-76.
2. Nakahara K, Ohno K, Hashimoto J, et al. Thymoma: results with complete resection and adjuvant postoperative irradiation in 141 consecutive patients. J Thorac Cardiovasc Surg 1988; 95: 1041-7.
3. Göldel N, Böning L, Fredrik A, Hölzel D, Hartenstein R, Wilmanns W. Chemotherapy of invasive thymoma. A retrospective study of 22 cases. Cancer 1989; 63: 1493-500.
4. Dy C, Calvo FA, Mindan JP, et al. Undifferentiated epithelial-rich invasive malignant thymoma: complete response to cisplatin, vinblastine, and bleomycin therapy. J Clin Oncol 1988; 6: 536-42.
5. Hu E, Levine J. Chemotherapy of malignant thymoma. Case report and review of the literature. Cancer 1986; 57: 1101-4.
6. Loehrer PJ, Perez CA, Roth LM, Greco A, Livingston RB, Einhorn LH. Chemotherapy for advanced thymoma. Preliminary results of an intergroup study. Ann Intern Med 1990; 113: 520-4.
7. Fornasiero A, Daniele O, Ghiotto C, et al. Chemotherapy for invasive thymoma. A 13-year experience. Cancer 1991; 68: 30-3.
8. Park HS, Shin DM, Lee JS, et al. Thymoma. A retrospective study of 87 cases. Cancer 1994; 73: 2491-8.
9. Tomiak EM, Evans WK. The role of chemotherapy in invasive thymoma: a review of the literature and considerations for future clinical trials. Crit Rev Oncol Hematol 1993; 15: 113-24.
10. Daugaard G, Hansen HH, Rørth M. Combination chemotherapy for malignant thymoma. Ann Intern Med 1983; 99: 189-90.
11. Masaoka A, Monden Y, Nakahara K, Tanioka T. Follow-up study of thymomas with special reference to their clinical stages. Cancer 1981; 48: 2485-92.
12. Hammond EH, Flinner RL. The diagnosis of thymoma: a review. Ultrastruct Pathol 1991; 15: 419-38.
13. Rosai J. Mediastinum. In: Rosai J, ed. Ackerman's surgical pathology. St. Louis: C V Mosby Company, 1989: 345-91.
14. Ohara K, Okumura T, Sugahara S, et al. The role of preoperative radiotherapy for invasive thymoma. Acta Oncol 1990; 29: 425-9.
15. Fujimara S, Konda T, Handa M, Shiraishi Y, Tamahashi N, Nakada T. Results of surgical treatment for thymoma based on 66 patients. J Thorac Cardiovasc Surg 1987; 93: 708-14.
16. Gaspard MH, Maraninchi D, Stoppa AM, et al. Intensive chemotherapy with high doses of BCNU, etoposide, cytosine arabinoside, and melphalan (BEAM) followed by autologous bone marrow transplantation: toxicity and antitumor activity in 26 patients with poor-risk malignancies. Cancer Chemother Pharmacol 1988; 22: 256-62.
17. Pedersen-Bjergaard J, Philip P, Larsen SO, et al. Therapy related myelodysplasia and acute myeloid leukemia. Cytogenetic characteristics of 115 consecutive cases and risk in seven cohorts of patients treated intensively for malignant diseases in the Copenhagen series. Leukemia 1993; 7: 1975-86.
18. Levine EG, Bloomfield CD. Leukemias and myelodysplastic syndromes secondary to drug, radiation, and environmental exposure. Semin Oncol 1992; 19: 47-84.
19. Batra P, Herrmann C, Mulder D. Mediastinal imaging in myasthenia gravis: correlation of chest radiography, CT, MR, and surgical findings. AJR 1987; 148: 515-9.